GHB for cataplexy: Possible mode of action

Journal of Psychopharmacology
Elemer Szabadi

Abstract

The sleep disorder narcolepsy is caused by the loss of orexinergic neurones in the lateral hypothalamus. A troublesome symptom of narcolepsy is cataplexy, the sudden loss of muscle tone in response to strong emotions. It can be alleviated by antidepressants and sodium oxybate (γ-hydroxybutyric acid (GHB)). It is likely that the noradrenergic nucleus locus coeruleus (LC) is involved since it is essential for the maintenance of muscle tone, and ceases to fire during cataplectic attacks. Furthermore, alpha-2 adrenoceptors proliferate in the LC in cataplexy, probably due to 'heterologous denervation supersensitivity' resulting from the loss/weakening of the orexinergic input to the LC. This would lead to the sensitization of the autoinhibition mechanism of LC neurones mediated by inhibitory alpha-2 adrenoceptors ('autoreceptors'). Thus the excitatory input from the amygdala to the LC, activated by an emotional stimulus, would lead to the 'switching off' of LC activity via the supersensitive auto-inhibition mechanism. GHB is an agonist at both γ-aminobutyric acid (GABA) GABA (B) and GHB receptors that may be a subtype of an extrasynaptic GABA(A) receptor. GHB may prevent a cataplectic attack by dampening the tone of LC neurones via ...Continue Reading

References

Apr 27, 1988·European Journal of Pharmacology·H R OlpeM F Pozza
Jan 1, 1985·European Neurology·R Sandyk
Feb 1, 1981·Annals of Neurology·P A PriceJ D Parkes
Nov 1, 1994·Neurology·O F D'CruzR S Greenwood
May 1, 1997·Progress in Neurobiology·S Nishino, E Mignot
Mar 4, 1998·Neurology·E Mignot
Jul 3, 1999·Neuroscience·M F WuJ M Siegel
Oct 19, 2001·CNS Drug Reviews·S A Anttila, E V Leinonen
Mar 23, 2004·Sleep Medicine·UNKNOWN U.S. Xyrem Multicenter Study Group
Sep 1, 2004·Sleep Medicine Reviews·William C HoughtonMichael Thorpy
Dec 20, 2005·Current Opinion in Pharmacology·Norman G Bowery
Dec 22, 2005·Current Opinion in Pharmacology·Vincenzo CrunelliNathalie Leresche
Jun 13, 2006·Trends in Pharmacological Sciences·Jamie M ZeitzerEmmanuel Mignot
Jul 14, 2006·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Virginie SterpenichPierre Maquet
Mar 27, 2007·CNS Drugs·Dean M Robinson, Gillian M Keating
May 2, 2007·Sleep Medicine·Seiji Nishino
Oct 4, 2007·Frontiers in Neuroendocrinology·Kousaku Ohno, Takeshi Sakurai
Jun 13, 2009·Pediatric Neurology·Yu-Shu Huang, Christian Guilleminault
Nov 3, 2010·Annual Review of Pharmacology and Toxicology·Thomas E Scammell, Christopher J Winrow
Nov 3, 2010·Nature Neuroscience·Matthew E CarterLuis de Lecea
Nov 26, 2010·Nature Neuroscience·Ronald McGregor, Jerome M Siegel
Feb 8, 2011·Current Neurology and Neuroscience Reports·Takashi KanbayashiSeiji Nishino
Mar 13, 2012·Frontiers in Molecular Neuroscience·Hong-Ping HuangZhuan Zhou
May 4, 2012·Expert Review of Neurotherapeutics·Geert Mayer
Jul 4, 2012·Clinical Toxicology : the Official Journal of the American Academy of Clinical Toxicology and European Association of Poisons Centres and Clinical Toxicologists·Leo J SchepBruno Mégarbane
Jul 4, 2012·Proceedings of the National Academy of Sciences of the United States of America·Nathan AbsalomPetrine Wellendorph
Aug 2, 2012·Proceedings of the National Academy of Sciences of the United States of America·S J Enna
Aug 16, 2012·Journal of Clinical Sleep Medicine : JCSM : Official Publication of the American Academy of Sleep Medicine·Mashael K AlshaikhAhmed S BaHammam
Sep 8, 2012·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Christian R Burgess, Thomas E Scammell
Jan 31, 2013·Current Pharmaceutical Design·Rodolfo Delgado-LezamaRicardo Felix

❮ Previous
Next ❯

Citations

Mar 12, 2016·Forensic Science International : Synergy·Francesco Paolo BusardòEnrico Marinelli
Jan 8, 2016·Medicinal Research Reviews·Michel MaitreAyikoe G Mensah-Nyagan
May 21, 2016·Journal of Clinical Pharmacology·C Michael White
Oct 16, 2020·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Shenglan ZhangJianfeng Liu
May 30, 2021·Science Advances·Hamidreza ShayeVadim Cherezov

❮ Previous
Next ❯

Related Concepts

Related Feeds

Amygdala: Sensory Processes

Amygdalae, nuclei clusters located in the temporal lobe of the brain, play a role in memory, emotional responses, and decision-making. Here is the latest research on sensory processes in the amygdala.

Amygdala and Midbrain Dopamine

The midbrain dopamine system is widely studied for its involvement in emotional and motivational behavior. Some of these neurons receive information from the amygdala and project throughout the cortex. When the circuit and transmission of dopamine is disrupted symptoms may present. Here is the latest research on the amygdala and midbrain dopamine.

Adrenergic Receptors: Trafficking

Adrenergic receptor trafficking is an active physiological process where adrenergic receptors are relocated from one region of the cell to another or from one type of cell to another. Discover the latest research on adrenergic receptor trafficking here.